PfizerPFEEarnings & Financial Report
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer (1824–1906) and Charles F. Erhart (1821–1891), Pfizer is one of the oldest pharmaceutical companies in North America.
Revenue
$14.7B
Gross Profit
$10.9B
Operating Profit
N/A
Net Profit
$2.9B
Gross Margin
74.2%
Operating Margin
N/A
Net Margin
19.9%
YoY Growth
10.3%
EPS
$0.51
Financial Flow
Pfizer Q2 2025 Financial Summary
Pfizer reported revenue of $14.7B for Q2 2025, with a net profit of $2.9B (19.9% margin). Cost of goods sold was $3.8B, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $14.7B |
|---|---|
| Net Profit | $2.9B |
| Gross Margin | 74.2% |
| Operating Margin | N/A |
| Report Period | Q2 2025 |
Pfizer Annual Revenue by Year
Pfizer annual revenue history includes year-by-year totals (for example, 2024 revenue was $63.6B).
| Year | Annual Revenue |
|---|---|
| 2024 | $63.6B |
| 2023 | $62.5B |
| 2022 | $101.7B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.23B | $14.88B | $13.28B | $17.70B | $17.76B | $13.71B | $14.65B | $16.65B |
| YoY Growth | -41.5% | N/A | -27.3% | 39.0% | 34.2% | -7.8% | 10.3% | -5.9% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $215.02B | $221.09B | $216.19B | $219.48B | $213.40B | $208.03B | $206.09B | $208.73B |
| Liabilities | $117.82B | $128.54B | $128.22B | $126.92B | $124.90B | $117.39B | $117.08B | $115.64B |
| Equity | $96.93B | $92.28B | $87.70B | $92.29B | $88.20B | $90.34B | $88.69B | $92.80B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $5.24B | $1.09B | $-1.78B | $6.71B | $6.72B | $2.33B | $-582.0M | $4.60B |
Other Health Care Companies
BMY
Bristol Myers Squibb
Revenue
$12.5B
Net Profit
$1.1B
JNJ
Johnson & Johnson
Revenue
$24.6B
Net Profit
$5.1B
LLY
Lilly (Eli)
Revenue
$19.3B
Net Profit
$6.6B
MRK
Merck & Co.
Revenue
$17.3B
Net Profit
$5.8B
VTRS
Viatris
Revenue
$3.7B
Net Profit
N/A
ZTS
Zoetis
Revenue
$2.4B
Net Profit
$603.0M
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M